
Quinacrine binds directly to the cellular prion protein (PrPC) and inhibits its conversion to the pathogenic scrapie form (PrPSc) by stabilizing the native α-helical structure. The drug interferes with the β-sheet formation characteristic of misfolded prions and may enhance clearance of existing aggregates through autophagy activation.
IPFS: QmbC2ypU6hBQjjQueWEyJYJDLrxE1MnYcgRYhRDHEapQAp. TX: 0x5774b4dead605eec685be171e31c52100e068d604f80fbd4b70370abdd607359. CC0.
Creutzfeldt-Jakob Disease, drug repurposing, MedicOath, repurposing
Creutzfeldt-Jakob Disease, drug repurposing, MedicOath, repurposing
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
